Huang JH, et al. Sci China Chem March (2013) Vol.56 No.3
351
stereomers, which was directly used for the next step.
ford 14 as a white solid (21 mg, 87%). 1H NMR (400 MHz,
CDCl3) 0.84 (s, 3H), 0.85–0.88 (m, 1H), 0.90 (s, 3H), 0.99
(s, 3H), 0.93–1.10 (m, 1H), 1.05–1.14 (m, 1H), 1.21 (d, J =
2.4 Hz, 1H), 1.25 (t, J = 3.6 Hz, 1H), 1.28–1.37 (m, 1H),
1.55 (s, 3H), 1.45–1.60 (m, 2H), 1.70–1.75 (m, 1H),
2.052.22 (m, 2H), 3.31 (q, J = 17.2, 7.6 Hz, 2H), 4.70 (s,
1H, OH), 5.07 (s, 1H, OH), 6.51–6.55 (m, 2H), 6.62–6.64
(m, 1H); 13CNMR (100 MHz, CDCl3) δ 18.8, 19.0, 20.2,
20.2, 21.7, 27.8, 33.2, 33.3, 33.5, 36.1, 39.0, 41.5, 51.7,
112.8, 115.8, 116.1, 128.2, 130.0, 137.2, 147.7, 149.1;
HRMS (ESI) [M+] calculated for C21H30O2: 314.2240, found:
314.2242; IR (neat) max: 3311, 2925, 2358, 1186 cm1;
[]2D2 +103.0 (c 0.5, MeOH).
To a stirred mixture of liquid NH3 (20 mL) and anhy-
drous THF (10 mL) at 78 °C was added Li (39 mg, 5.6
mmol). After stirred for 15 min, a solution of 17 (314 mg,
crude from previous step) in THF (5 mL) was added. The
resulting solution was stirred at 78 °C for 15 min, then
quenched with solid NH4Cl (1.00 g) and the NH3 was al-
lowed to evaporate by warming to room temperature. The
resultant mixture was diluted with H2O (50 mL) and ex-
tracted with Et2O (3 × 15 mL). The organic phases were
combined, dried over MgSO4, filtered and concentrated in
vacuo. The crude product was purified by flash column
chromatography using PE to afford 18 as a colorless oil
(230 mg, 75% over two steps). 1H NMR (400 MHz, CDCl3)
0.15 (s, 6H), 0.19 (s, 6H), 0.84 (s, 3H), 0.90 (s, 3H), 0.95
(s, 9H), 0.99 (s, 3H), 1.02 (s, 9H), 1.04–1.11 (m, 1H),
1.23–1.36 (m, 4H), 1.49 (s, 3H), 1.45–1.56 (m, 4H),
1.71–1.76 (m, 1H), 2.05–2.22 (m, 2H), 3.17 (d, J = 17.6 Hz,
1H), 3.32 (d, J = 17.6 Hz, 1H), 6.49–6.55 (m, 2H), 6.61 (d,
J = 8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) 4.28,
4.26, 4.14,4.11, 18.3, 18.3, 18.8, 19.2, 20.1, 20.3, 21.6,
25.8, 25.9, 27.6, 33.3, 33.5, 35.8, 38.8, 41.7, 52.0, 117.1,
118.7, 120.1, 128.6, 132.5, 137.7, 147.3, 149.4; HRMS (ESI)
[M+H+] calculated for C33H59O2Si2: 543.4048, found:
543.4051; IR (neat) max: 2928, 1487, 1251, 1203, 837, 777
cm1; []D21 +72.4 (c 0.49, CHCl3).
2.4 Synthesis of (+)-ent-chromazonarol (7)
To a solution of 14 (31 mg, 0.1 mmol) in CH2Cl2 (2 mL) at
20 °C was added BF3·Et2O (0.06 mL, 0.5 mmol). The re-
action mixture was stirred at 20 °C for 2 h, and then
quenched with saturated NH4Cl solution. The mixture was
then extracted with CH2Cl2 (15 mL). The organic phases
were combined, dried over MgSO4, filtered and concentrat-
ed in vacuo. The crude material was purified by flash col-
umn chromatography (EtOAc:PE = 1:7) to afford (+)-ent-
chromazonarol (7) as a white solid (30 mg, 95%). 1H NMR
(400 MHz, CDCl3) δ 0.84 (s, 3H), 0.87 (s, 3H), 0.90 (s, 3H),
0.93–0.98 (m, 1H), 1.02 (dd, J = 12.4, 2.4 Hz, 1H), 1.13–
1.20 (m, 1H), 1.17 (s, 3H), 1.25–1.49 (m, 3H), 1.61–1.62 (m,
1H), 1.63–1.70 (m, 3H), 1.72–1.78 (m, 1H), 2.04 (dt, J =
12.4, 2.8 Hz, 1H), 2.56–2.58 (m, 2H), 4.55 (s, 1H, OH),
6.55–6.58 (m, 2H), 6.62 (d, J = 8.8 Hz, 1H); 13C NMR (100
MHz, CDCl3) δ 14.8, 18.5, 19.7, 20.6, 21.6, 22.5, 33.1, 33.4,
36.7, 39.1, 41.1, 41.8, 52.0, 56.1, 76.7, 114.2, 115.8, 117.5,
123.3, 147.0, 148.5; HRMS (ESI) [M+] calculated for
C21H30O2: 314.2240, found: 314.2241; IR (neat) max: 3372,
2926, 2359, 1493 cm1; []D23 +42.0 (c 1.0, CHCl3).
2.3 Synthesis of compound 14
To a solution of 18 (43 mg, 0.08 mmol) in THF (1.5 mL)
was added TBAF (1 M in THF, 0.17 mL, 0.17 mmol) at
0 °C. The reaction was stirred at 0 °C for 20 min, then
quenched with water (5 mL) and extracted with Et2O (3 × 5
mL). The organic phases were combined, dried over MgSO4,
filtered and concentrated in vacuo. The residue was purified
by flash column chromatography (EtOAc:PE = 1:5) to af-
Scheme 2 Retrosynthetic plan for (+)-ent-chromazonarol (7).